All In Biotech

Drug Trial Radar · NCT07361302

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

TENACITY - A Phase III, Prospective, Randomized, Open-label, Blinded Endpoint Assessment (PROBE) to Assess Efficacy and Safety of i.v. Tenecteplase vs Standard of Care in Patients With Acute Ischemic Stroke (Including Wake-up Stroke), Last Known Well >4.5 h With Imaging Evidence of Salvageable Ischemic Tissue

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,325 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,325

Planned (sponsor's estimate)

Start

Feb 17, 2026

Primary completion

Oct 2, 2027

Study completion Oct 2, 2027

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is open to adults who had an acute stroke caused by a clot blocking a blood vessel in the brain (acute ischemic stroke). This study is for people who had an acute stroke or woke up with a stroke and were last seen well more than 4.5 hours before joining the study. Participants need to have imaging that shows there is brain tissue that can still be saved. They also should not be planned to receive a procedure to remove the blood clot. The purpose of this study is to find out whether a medicine called tenecteplase helps people recover from an acute stroke. Tenecteplase is already used to treat people within 4.5 hours after they had a stroke. This study tests if tenecteplase also helps if it is given more than 4.5 hours after the stroke. Participants are put into 2 groups randomly, which means by chance. One group gets tenecteplase as a single injection into a vein. The other group receives standard medical practice. Participants have an equal chance of receiving tenecteplase or the standard treatment. Participants are in the study for about 3 months. In the beginning, participants stay in the hospital for about 1 week. During the study, participants have 7 clinical examinations or visits. The last 2 of these visits will likely be done from home, allowing participants to complete certain assessments remotely. Doctors regularly test participants' recovery using a scale that measures the level of disability or dependence in daily activities. The results are compared between the 2 groups to see whether the treatment works. The doctors also check participants' health and take note of any unwanted effects.

Conditions

  • Acute Ischemic Stroke

Interventions

  • TenecteplaseDrug

    Tenecteplase

  • Standard of care treatmentDrug

    Standard of care treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. modified Rankin Scale (mRS) score of 0-1 at Day 90Time frame: at day 90

Locations

258 sites in 16 countries. Site status is shown where the registry gives one.

  • Sanatorio Güemes

    Buenos Aires, Argentina · Recruiting

  • Hospital Italiano de Buenos Aires

    Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting

  • CEMIC

    Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting

  • Hospital General de Agudos Dr. J. M. Ramos Mejia

    Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting

  • Clinica La Sagrada Familia

    Ciudad Autonoma Buenos Aires, Argentina · Recruiting

  • Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia - FLENI

    Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting

  • Complejo Medico de la Policia Federal Argentina Churruca Visca

    Ciudad Autonoma Buenos Aires, Argentina · Not yet recruiting

  • Clinica Privada Velez Sarfield

    Córdoba, Argentina · Recruiting

  • Nuevo Hospital San Roque

    Córdoba, Argentina · Recruiting

  • Sanatorio Allende

    Córdoba, Argentina · Recruiting

  • Sanatorio Privado Duarte Quiros De Clinica Colombo SA

    Córdoba, Argentina · Recruiting

  • Sanatorio de la Canada

    Córdoba, Argentina · Recruiting

  • Hospital Cordoba

    Córdoba, Argentina · Recruiting

  • Hospital Privado de Comunidad

    Mar del Plata, Argentina · Not yet recruiting

  • Hospital Universitario Austral

    Pilar, Argentina · Recruiting

  • Hospital Privado de Rosario

    Rosario, Argentina · Recruiting

  • Campbelltown Hospital

    Campbelltown, New South Wales, Australia · Recruiting

  • Liverpool Hospital

    Liverpool, New South Wales, Australia · Recruiting

  • John Hunter Hospital

    New Lambton Heights, New South Wales, Australia · Recruiting

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia · Recruiting

  • Eastern Health-Box Hill Hospital

    Box Hill, Victoria, Australia · Recruiting

  • Monash Medical Centre

    Clayton, Victoria, Australia · Recruiting

  • Royal Melbourne Hospital

    Parkville, Victoria, Australia · Recruiting

  • MHAT "Puls" AD

    Blagoevgrad, Bulgaria · Recruiting

  • MHAT Blagoevgrad, EOOD

    Blagoevgrad, Bulgaria · Recruiting

  • MHAT Heart and brain

    Burgas, Bulgaria · Recruiting

  • MHAT Sv. Ivan Rilski EOOD

    Gorna Oryahovitsa, Bulgaria · Recruiting

  • MHAT City Clinic Saint Georgi Ltd

    Montana, Bulgaria · Recruiting

  • MHAT Heart and brain

    Pleven, Bulgaria · Not yet recruiting

  • University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD

    Pleven, Bulgaria · Recruiting

  • UMHAT "Kaspela", EOOD

    Plovdiv, Bulgaria · Recruiting

  • UMHAT "Sv. Georgi", EAD

    Plovdiv, Bulgaria · Recruiting

  • UMHAT Kanev AD

    Rousse, Bulgaria · Recruiting

  • UMHAT "Medika Ruse" OOD

    Rousse, Bulgaria · Recruiting

  • Multiprofile Hospital For Active Treatment Hadji Dimitar OOD

    Silven, Bulgaria · Recruiting

  • MHATNP "Sv. Naum" EAD

    Sofia, Bulgaria · Recruiting

  • University First MHAT-Sofia "St. Joan Krastitel" EAD

    Sofia, Bulgaria · Recruiting

  • Acibadem City Clinic Tokuda University Hospital EAD

    Sofia, Bulgaria · Recruiting

  • Medical Military Academy MHAT Sofia

    Sofia, Bulgaria · Recruiting

  • Multiprofile Hospital MHATEM 'Pirogov', Sofia

    Sofia, Bulgaria · Recruiting

Showing 40 of 258 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.